Free Meningitis B Vaccine Offered at Pharmacies Across England
High street pharmacies throughout England are now providing a free meningitis B vaccine to many young individuals. This initiative follows concerns regarding the UK's largest and fastest-growing meningitis B outbreak, which occurred in Kent earlier this year.
Who is eligible for the vaccine, and what does it contain?
What Is the Vaccine and Is It Safe?
The vaccine protects against meningitis B (MenB), a dangerous strain responsible for the outbreak in Kent. Importantly, the vaccine does not contain any live bacteria and cannot cause meningitis.
Common side effects include swelling, redness, or tenderness at the injection site. Some recipients may also experience mild fever, nausea, headache, or muscle aches, which typically resolve within one to two days. Serious side effects are rare.
How Can I Book the Vaccine?
Appointments can be booked at participating high street pharmacies across England starting Monday, 13 July, with the earliest appointments available from Monday, 20 July.
Seventeen and eighteen-year-olds can book via the NHS National Booking Service if they are registered with a GP.
Other students under 25 who are beginning residential college or university for the first time this autumn may also contact participating pharmacies.
Walk-in MenB vaccinations are available at pharmacies for individuals born on or after 21 July 2001 who are, for the first time this autumn:
- Starting at a further education college as a residential student
International students and students from other parts of the UK (Scotland, Wales, Northern Ireland, the Channel Islands, the Isle of Man) studying in England are eligible, as are those traveling abroad to study.
Registration with a GP surgery is not required to use the walk-in service.
Find a participating pharmacy here.
Who Is Eligible for the MenB Vaccine?
The vaccine, administered in two doses at least 28 days apart, is offered to 17 and 18-year-olds in sixth form and students under 25 starting residential college or university for the first time this autumn. Both doses are necessary for full protection.
Approximately one million young people in England are expected to be eligible, including:
- Individuals born between 1 September 2007 and 31 August 2008
- Those born on or after 21 July 2001 starting university for the first time this autumn
- Those born on or after 21 July 2001 starting residential further education colleges for the first time this autumn
Why Are Students Advised to Get the Vaccine?
The meningitis outbreak in Kent in March was described as unprecedented and explosive. Within weeks, there were 29 confirmed or suspected cases and two deaths in Kent.
Consequently, a new one-off campaign has been launched to protect those at greatest risk and to help prevent a similar outbreak.
Students in their first year of university have a risk about seven times higher than young people of a similar age who do not attend university, says NHS England.
Meningitis infections spread through close contact, such as kissing, sharing vapes and drinks, or living in close quarters with an infected person.
UK health officials note that the risk to 18-year-olds or those entering university or residential college for the first time is higher due to increased social mixing and shared accommodation.
How Dangerous Is Meningitis B?
MenB infection can cause severe, life-threatening conditions such as inflammation of the brain lining (meningitis) and blood poisoning (sepsis). It may result in life-changing disabilities including amputations, hearing loss, and brain damage, and can be fatal in some cases.
Why Not Vaccinate All Teenagers?
The MenB vaccine was incorporated into the UK NHS childhood immunisation programme for babies born on or after 1 July 2015; all babies now receive it. However, teenagers and young adults over 11 years old have not been routinely vaccinated.
Young infants are vaccinated because they are more susceptible to invasive infections and less able to fight them off.
Research indicates that the MenB vaccine does not necessarily prevent transmission between individuals, does not target all B bacteria strains, and does not provide long-term protection.
UK vaccine experts have concluded it is not cost-effective to offer the MenB vaccine to all adolescents. Nonetheless, they encourage all eligible individuals to receive the vaccine to prevent serious illness.
Approximately 10,000 people in the Kent region have already been vaccinated as part of the response to the March outbreak.
What About the Rest of the UK?
Each UK nation has its own plans but all are offering the vaccine to most pupils completing Year 13 or S6 in summer 2026, regardless of education plans, including those not currently in school.
Young people aged 18-25 starting university or residential further education for the first time in autumn 2026 are also eligible.
In Wales, 17-18-year-olds will receive letters from health boards starting early July, while 18-25-year-olds entering higher education will need to contact their health board later in July.
What About Other Types of Meningitis?
Meningitis can be caused by various viruses or bacteria, transmitted through close contact with an infected person.
Viral meningitis usually resolves within seven to ten days and can often be managed at home with rest, painkillers, and anti-sickness medication.
Bacterial meningitis requires hospital treatment.
Currently, the MenACWY vaccine, covering different strains, is routinely offered to 14-year-olds.
